Application of Adipose-Derived Stem Cells in Heart Disease

Journal of Cardiovascular Translational Research

Volumn 7, Issue 7, 2014, Pages 651-663

  Chen, Lina ^a   Qin, Fengming ^a   Ge, Menghua ^a   Shu, Qiang ^b   Xu, Jianguo ^a,b  

^a Shaoxing Second Hospital   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Adipose derived stem cells; Heart disease; Mesenchymal stem cells; Myocardial infarction

Indexed keywords

CD4 ANTIGEN; CYCLOOXYGENASE 2; HLA G ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; PROSTAGLANDIN E2; SCATTER FACTOR; SOMATOMEDIN C; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL ENGINEERING; CELL FUNCTION; CELL ISOLATION; CELLULAR SECRETION; CLINICAL TRIAL (TOPIC); CYTOKINE RESPONSE; DISEASE MODEL; ENGRAFTMENT; GENETIC ENGINEERING; HEART ATRIUM REMODELING; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE REMODELING; HUMAN; IMMUNOREGULATION; INTERMETHOD COMPARISON; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; REGULATORY T LYMPHOCYTE; STROMAL VASCULAR FRACTION CELL; VASCULARIZATION; ADIPOSE TISSUE; ANIMAL; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; CONVALESCENCE; CYTOLOGY; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; GRAFT SURVIVAL; HEART DISEASES; IMMUNOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; PARACRINE SIGNALING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION; REGENERATIVE MEDICINE; TREATMENT OUTCOME;

ANIMALIA;

ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETIC THERAPY; GRAFT SURVIVAL; HEART DISEASES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PARACRINE COMMUNICATION; RECOVERY OF FUNCTION; REGENERATION; REGENERATIVE MEDICINE; TREATMENT OUTCOME;

EID: 84919705703     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-014-9585-1     Document Type: Article

References (107)

1. Beltrami, A. P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K., Leri, A., Kajstura, J., Nadal-Ginard, B., & Anversa, P. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114(6), 763–776.
2. Williams, A. R., Hatzistergos, K. E., Addicott, B., McCall, F., Carvalho, D., Suncion, V., Morales, A. R., Da Silva, J., Sussman, M. A., Heldman, A. W., & Hare, J. M. (2013). Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation, 127(2), 213–223. doi:10.1161/CIRCULATIONAHA.112.131110.
3. Quevedo, H. C., Hatzistergos, K. E., Oskouei, B. N., Feigenbaum, G. S., Rodriguez, J. E., Valdes, D., Pattany, P. M., Zambrano, J. P., Hu, Q., McNiece, I., Heldman, A. W., & Hare, J. M. (2009). Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proceedings of the National Academy of Sciences of the United States of America, 106(33), 14022–14027. doi:10.1073/pnas.0903201106.
4. Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., Gerstenblith, G., DeMaria, A. N., Denktas, A. E., Gammon, R. S., Hermiller, J. B., Jr., Reisman, M. A., Schaer, G. L., & Sherman, W. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology, 54(24), 2277–2286. doi:10.1016/j.jacc.2009.06.055.
5. Williams, A. R., Trachtenberg, B., Velazquez, D. L., McNiece, I., Altman, P., Rouy, D., Mendizabal, A. M., Pattany, P. M., Lopera, G. A., Fishman, J., Zambrano, J. P., Heldman, A. W., & Hare, J. M. (2011). Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circulation Research, 108(7), 792–796. doi:10.1161/CIRCRESAHA.111.242610.
6. Heldman, A. W., DiFede, D. L., Fishman, J. E., Zambrano, J. P., Trachtenberg, B. H., Karantalis, V., Mushtaq, M., Williams, A. R., Suncion, V. Y., McNiece, I. K., Ghersin, E., Soto, V., Lopera, G., Miki, R., Willens, H., Hendel, R., Mitrani, R., Pattany, P., Feigenbaum, G., Oskouei, B., Byrnes, J., Lowery, M. H., Sierra, J., Pujol, M. V., Delgado, C., Gonzalez, P. J., Rodriguez, J. E., Bagno, L. L., Rouy, D., Altman, P., Foo, C. W., da Silva, J., Anderson, E., Schwarz, R., Mendizabal, A., & Hare, J. M. (2014). Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA: The Journal of the American Medical Association, 311(1), 62–73. doi:10.1001/jama.2013.282909.
7. Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., & Hedrick, M. H. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering, 7(2), 211–228. doi:10.1089/107632701300062859.
8. In ‘t Anker, P. S., Scherjon, S. A., Kleijburg-van der Keur, C., de Groot-Swings, G. M., Claas, F. H., Fibbe, W. E., & Kanhai, H. H. (2004). Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells, 22(7), 1338–1345. doi:10.1634/stemcells.2004-0058.
9. Erices, A., Conget, P., & Minguell, J. J. (2000). Mesenchymal progenitor cells in human umbilical cord blood. British Journal of Haematology, 109(1), 235–242.
10. Troyer, D. L., & Weiss, M. L. (2008). Wharton’s jelly-derived cells are a primitive stromal cell population. Stem Cells, 26(3), 591–599. doi:10.1634/stemcells.2007-0439.
11. Gronthos, S., Brahim, J., Li, W., Fisher, L. W., Cherman, N., Boyde, A., DenBesten, P., Robey, P. G., & Shi, S. (2002). Stem cell properties of human dental pulp stem cells. Journal of Dental Research, 81(8), 531–535.
12. Gimble, J. M., Katz, A. J., & Bunnell, B. A. (2007). Adipose-derived stem cells for regenerative medicine. Circulation Research, 100(9), 1249–1260. doi:10.1161/01.RES.0000265074.83288.09.
13. Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002). Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell, 13(12), 4279–4295. doi:10.1091/mbc.E02-02-0105.
14. Przybyt, E., & Harmsen, M. C. (2013). Mesenchymal stem cells: promising for myocardial regeneration? Current Stem Cell Research & Therapy, 8(4), 270–277.
15. Baer, P. C., & Geiger, H. (2012). Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells International, 2012, 812693. doi:10.1155/2012/812693.
16. Pikula, M., Marek-Trzonkowska, N., Wardowska, A., Renkielska, A., & Trzonkowski, P. (2013). Adipose tissue-derived stem cells in clinical applications. Expert Opinion on Biological Therapy, 13(10), 1357–1370. doi:10.1517/14712598.2013.823153.
17. Caplan, A. I. (1991). Mesenchymal stem cells. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society, 9(5), 641–650. doi:10.1002/jor.1100090504.
18. Friedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell and Tissue Kinetics, 3(4), 393–403.
19. Friedenstein, A. J., Chailakhyan, R. K., Latsinik, N. V., Panasyuk, A. F., & Keiliss-Borok, I. V. (1974). Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation, 17(4), 331–340.
20. Van, R. L., Bayliss, C. E., & Roncari, D. A. (1976). Cytological and enzymological characterization of adult human adipocyte precursors in culture. The Journal of Clinical Investigation, 58(3), 699–704. doi:10.1172/JCI108516.
21. Bourin, P., Bunnell, B. A., Casteilla, L., Dominici, M., Katz, A. J., March, K. L., Redl, H., Rubin, J. P., Yoshimura, K., & Gimble, J. M. (2013). Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy, 15(6), 641–648. doi:10.1016/j.jcyt.2013.02.006.
22. Tang, W., Zeve, D., Suh, J. M., Bosnakovski, D., Kyba, M., Hammer, R. E., Tallquist, M. D., & Graff, J. M. (2008). White fat progenitor cells reside in the adipose vasculature. Science, 322(5901), 583–586. doi:10.1126/science.1156232.
23. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., & Horwitz, E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315–317. doi:10.1080/14653240600855905.
24. Mosna, F., Sensebe, L., & Krampera, M. (2010). Human bone marrow and adipose tissue mesenchymal stem cells: a user’s guide. Stem Cells and Development, 19(10), 1449–1470. doi:10.1089/scd.2010.0140.
25. Zheng, G., Huang, L., Tong, H., Shu, Q., Hu, Y., Ge, M., Deng, K., Zhang, L., Zou, B., Cheng, B., & Xu, J. (2014). Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study. Respiratory Research, 15(1), 39. doi:10.1186/1465-9921-15-39.
26. Strioga, M., Viswanathan, S., Darinskas, A., Slaby, O., & Michalek, J. (2012). Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells and Development, 21(14), 2724–2752. doi:10.1089/scd.2011.0722.
27. Onate, B., Vilahur, G., Ferrer-Lorente, R., Ybarra, J., Diez-Caballero, A., Ballesta-Lopez, C., Moscatiello, F., Herrero, J., & Badimon, L. (2012). The subcutaneous adipose tissue reservoir of functionally active stem cells is reduced in obese patients. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 26(10), 4327–4336. doi:10.1096/fj.12-207217.
28. Oedayrajsingh-Varma, M. J., van Ham, S. M., Knippenberg, M., Helder, M. N., Klein-Nulend, J., Schouten, T. E., Ritt, M. J., & van Milligen, F. J. (2006). Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy, 8(2), 166–177. doi:10.1080/14653240600621125.
29. Mitchell, J. B., McIntosh, K., Zvonic, S., Garrett, S., Floyd, Z. E., Kloster, A., Di Halvorsen, Y., Storms, R. W., Goh, B., Kilroy, G., Wu, X., & Gimble, J. M. (2006). Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells, 24(2), 376–385. doi:10.1634/stemcells.2005-0234.
30. Jurgens, W. J., Oedayrajsingh-Varma, M. J., Helder, M. N., Zandiehdoulabi, B., Schouten, T. E., Kuik, D. J., Ritt, M. J., & van Milligen, F. J. (2008). Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies. Cell and Tissue Research, 332(3), 415–426. doi:10.1007/s00441-007-0555-7.
31. Schipper, B. M., Marra, K. G., Zhang, W., Donnenberg, A. D., & Rubin, J. P. (2008). Regional anatomic and age effects on cell function of human adipose-derived stem cells. Annals of Plastic Surgery, 60(5), 538–544. doi:10.1097/SAP.0b013e3181723bbe.
32. Frazier, T. P., Gimble, J. M., Devay, J. W., Tucker, H. A., Chiu, E. S., & Rowan, B. G. (2013). Body mass index affects proliferation and osteogenic differentiation of human subcutaneous adipose tissue-derived stem cells. BMC Cell Biology, 14, 34. doi:10.1186/1471-2121-14-34.
33. Minteer, D., Marra, K. G., & Rubin, J. P. (2013). Adipose-derived mesenchymal stem cells: biology and potential applications. Advances in Biochemical Engineering/Biotechnology, 129, 59–71. doi:10.1007/10_2012_146.
34. Rangappa, S., Fen, C., Lee, E. H., Bongso, A., & Sim, E. K. (2003). Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. The Annals of Thoracic Surgery, 75(3), 775–779.
35. van Dijk, A., Niessen, H. W., Zandieh Doulabi, B., Visser, F. C., & van Milligen, F. J. (2008). Differentiation of human adipose-derived stem cells towards cardiomyocytes is facilitated by laminin. Cell and Tissue Research, 334(3), 457–467. doi:10.1007/s00441-008-0713-6.
36. Park, E., & Patel, A. N. (2010). Changes in the expression pattern of mesenchymal and pluripotent markers in human adipose-derived stem cells. Cell Biology International, 34(10), 979–984. doi:10.1042/CBI20100124.
37. Chang, W., Lim, S., Song, B. W., Lee, C. Y., Park, M. S., Chung, Y. A., Yoon, C., Lee, S. Y., Ham, O., Park, J. H., Choi, E., Maeng, L. S., & Hwang, K. C. (2012). Phorbol myristate acetate differentiates human adipose-derived mesenchymal stem cells into functional cardiogenic cells. Biochemical and Biophysical Research Communications, 424(4), 740–746. doi:10.1016/j.bbrc.2012.07.022.
38. Gaustad, K. G., Boquest, A. C., Anderson, B. E., Gerdes, A. M., & Collas, P. (2004). Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochemical and Biophysical Research Communications, 314(2), 420–427.
39. Peran, M., Marchal, J. A., Lopez, E., Jimenez-Navarro, M., Boulaiz, H., Rodriguez-Serrano, F., Carrillo, E., Sanchez-Espin, G., de Teresa, E., Tosh, D., & Aranega, A. (2010). Human cardiac tissue induces transdifferentiation of adult stem cells towards cardiomyocytes. Cytotherapy, 12(3), 332–337. doi:10.3109/14653240903548202.
40. Planat-Benard, V., Menard, C., Andre, M., Puceat, M., Perez, A., Garcia-Verdugo, J. M., Penicaud, L., & Casteilla, L. (2004). Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circulation Research, 94(2), 223–229. doi:10.1161/01.RES.0000109792.43271.47.
41. Song, Y. H., Gehmert, S., Sadat, S., Pinkernell, K., Bai, X., Matthias, N., & Alt, E. (2007). VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes. Biochemical and Biophysical Research Communications, 354(4), 999–1003. doi:10.1016/j.bbrc.2007.01.095.
42. Lee, W. C., Sepulveda, J. L., Rubin, J. P., & Marra, K. G. (2009). Cardiomyogenic differentiation potential of human adipose precursor cells. International Journal of Cardiology, 133(3), 399–401. doi:10.1016/j.ijcard.2007.11.068.
43. Zhang, F. B., Li, L., Fang, B., Zhu, D. L., Yang, H. T., & Gao, P. J. (2005). Passage-restricted differentiation potential of mesenchymal stem cells into cardiomyocyte-like cells. Biochemical and Biophysical Research Communications, 336(3), 784–792. doi:10.1016/j.bbrc.2005.08.177.
44. Yanez, R., Lamana, M. L., Garcia-Castro, J., Colmenero, I., Ramirez, M., & Bueren, J. A. (2006). Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells, 24(11), 2582–2591. doi:10.1634/stemcells.2006-0228.
45. Aust, L., Devlin, B., Foster, S. J., Halvorsen, Y. D., Hicok, K., du Laney, T., Sen, A., Willingmyre, G. D., & Gimble, J. M. (2004). Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy, 6(1), 7–14. doi:10.1080/14653240310004539.
46. Constantin, G., Marconi, S., Rossi, B., Angiari, S., Calderan, L., Anghileri, E., Gini, B., Bach, S. D., Martinello, M., Bifari, F., Galie, M., Turano, E., Budui, S., Sbarbati, A., Krampera, M., & Bonetti, B. (2009). Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells, 27(10), 2624–2635. doi:10.1002/stem.194.
47. Saka, Y., Furuhashi, K., Katsuno, T., Kim, H., Ozaki, T., Iwasaki, K., Haneda, M., Sato, W., Tsuboi, N., Ito, Y., Matsuo, S., Kobayashi, T., & Maruyama, S. (2011). Adipose-derived stromal cells cultured in a low-serum medium, but not bone marrow-derived stromal cells, impede xenoantibody production. Xenotransplantation, 18(3), 196–208. doi:10.1111/j.1399-3089.2011.00640.x.
48. DelaRosa, O., Sanchez-Correa, B., Morgado, S., Ramirez, C., del Rio, B., Menta, R., Lombardo, E., Tarazona, R., & Casado, J. G. (2012). Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis. Stem Cells and Development, 21(8), 1333–1343. doi:10.1089/scd.2011.0139.
49. Gonzalez-Rey, E., Anderson, P., Gonzalez, M. A., Rico, L., Buscher, D., & Delgado, M. (2009). Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut, 58(7), 929–939. doi:10.1136/gut.2008.168534.
50. Crop, M. J., Baan, C. C., Korevaar, S. S., Ijzermans, J. N., Pescatori, M., Stubbs, A. P., van Ijcken, W. F., Dahlke, M. H., Eggenhofer, E., Weimar, W., & Hoogduijn, M. J. (2010). Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells. Clinical and Experimental Immunology, 162(3), 474–486. doi:10.1111/j.1365-2249.2010.04256.x.
51. Gonzalez, M. A., Gonzalez-Rey, E., Rico, L., Buscher, D., & Delgado, M. (2009). Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology, 136(3), 978–989. doi:10.1053/j.gastro.2008.11.041.
52. Ono, K., Matsumori, A., Shioi, T., Furukawa, Y., & Sasayama, S. (1998). Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation, 98(2), 149–156.
53. Kilic, T., Ural, D., Ural, E., Yumuk, Z., Agacdiken, A., Sahin, T., Kahraman, G., Kozdag, G., Vural, A., & Komsuoglu, B. (2006). Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome. Heart, 92(8), 1041–1046. doi:10.1136/hrt.2005.080382.
54. Paul, A., Srivastava, S., Chen, G., Shum-Tim, D., & Prakash, S. (2013). Functional assessment of adipose stem cells for xenotransplantation using myocardial infarction immunocompetent models: comparison with bone marrow stem cells. Cell Biochemistry and Biophysics, 67(2), 263–273. doi:10.1007/s12013-011-9323-0.
55. Adutler-Lieber, S., Ben-Mordechai, T., Naftali-Shani, N., Asher, E., Loberman, D., Raanani, E., & Leor, J. (2013). Human macrophage regulation via interaction with cardiac adipose tissue-derived mesenchymal stromal cells. Journal of Cardiovascular Pharmacology and Therapeutics, 18(1), 78–86. doi:10.1177/1074248412453875.
56. Wang, H., Shi, J., Wang, Y., Yin, Y., Wang, L., Liu, J., Liu, Z., Duan, C., Zhu, P., & Wang, C. (2014). Promotion of cardiac differentiation of brown adipose derived stem cells by chitosan hydrogel for repair after myocardial infarction. Biomaterials, 35(13), 3986–3998. doi:10.1016/j.biomaterials.2014.01.021.
57. Rigol, M., Solanes, N., Roura, S., Roque, M., Novensa, L., Dantas, A. P., Martorell, J., Sitges, M., Ramirez, J., Bayes-Genis, A., & Heras, M. (2014). Allogeneic adipose stem cell therapy in acute myocardial infarction. European Journal of Clinical Investigation, 44(1), 83–92. doi:10.1111/eci.12195.
58. Geng, Y. J. (2003). Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure. Annals of the New York Academy of Sciences, 1010, 687–697.
59. Otto Beitnes, J., Oie, E., Shahdadfar, A., Karlsen, T., Muller, R. M., Aakhus, S., Reinholt, F. P., & Brinchmann, J. E. (2012). Intramyocardial injections of human mesenchymal stem cells following acute myocardial infarction modulate scar formation and improve left ventricular function. Cell Transplantation, 21(8), 1697–1709. doi:10.3727/096368911X627462.
60. Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm-Grove, C. J., Bovenkerk, J. E., Pell, C. L., Johnstone, B. H., Considine, R. V., & March, K. L. (2004). Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation, 109(10), 1292–1298. doi:10.1161/01.CIR.0000121425.42966.F1.
61. Wang, L., Deng, J., Tian, W., Xiang, B., Yang, T., Li, G., Wang, J., Gruwel, M., Kashour, T., Rendell, J., Glogowski, M., Tomanek, B., Freed, D., Deslauriers, R., Arora, R. C., & Tian, G. (2009). Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. American Journal of Physiology. Heart and Circulatory Physiology, 297(3), H1020–H1031. doi:10.1152/ajpheart.01082.2008.
62. Tang, J. M., Wang, J. N., Zhang, L., Zheng, F., Yang, J. Y., Kong, X., Guo, L. Y., Chen, L., Huang, Y. Z., Wan, Y., & Chen, S. Y. (2011). VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Cardiovascular Research, 91(3), 402–411. doi:10.1093/cvr/cvr053.
63. Miyahara, Y., Nagaya, N., Kataoka, M., Yanagawa, B., Tanaka, K., Hao, H., Ishino, K., Ishida, H., Shimizu, T., Kangawa, K., Sano, S., Okano, T., Kitamura, S., & Mori, H. (2006). Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nature Medicine, 12(4), 459–465. doi:10.1038/nm1391.
64. van Dijk, A., Naaijkens, B. A., Jurgens, W. J., Nalliah, K., Sairras, S., van der Pijl, R. J., Vo, K., Vonk, A. B., van Rossum, A. C., Paulus, W. J., van Milligen, F. J., & Niessen, H. W. (2011). Reduction of infarct size by intravenous injection of uncultured adipose derived stromal cells in a rat model is dependent on the time point of application. Stem Cell Research, 7(3), 219–229. doi:10.1016/j.scr.2011.06.003.
65. Bussolino, F., Di Renzo, M. F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A., & Comoglio, P. M. (1992). Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. The Journal of Cell Biology, 119(3), 629–641.
66. Nakamura, T., Mizuno, S., Matsumoto, K., Sawa, Y., Matsuda, H., & Nakamura, T. (2000). Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. The Journal of Clinical Investigation, 106(12), 1511–1519. doi:10.1172/JCI10226.
67. Nakamura, T., Matsumoto, K., Mizuno, S., Sawa, Y., Matsuda, H., & Nakamura, T. (2005). Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. American Journal of Physiology. Heart and Circulatory Physiology, 288(5), H2131–H2139. doi:10.1152/ajpheart.01239.2003.
68. Mehrhof, F. B., Muller, F. U., Bergmann, M. W., Li, P., Wang, Y., Schmitz, W., Dietz, R., & von Harsdorf, R. (2001). In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein. Circulation, 104(17), 2088–2094.
69. Funatsu, T., Sawa, Y., Ohtake, S., Takahashi, T., Matsumiya, G., Matsuura, N., Nakamura, T., & Matsuda, H. (2002). Therapeutic angiogenesis in the ischemic canine heart induced by myocardial injection of naked complementary DNA plasmid encoding hepatocyte growth factor. The Journal of Thoracic and Cardiovascular Surgery, 124(6), 1099–1105. doi:10.1067/mtc.2002.123809.
70. Madonna, R., & De Caterina, R. (2010). Adipose tissue: a new source for cardiovascular repair. Journal of Cardiovascular Medicine, 11(2), 71–80. doi:10.2459/JCM.0b013e328330e9be.
71. Bai, X., Yan, Y., Song, Y. H., Seidensticker, M., Rabinovich, B., Metzele, R., Bankson, J. A., Vykoukal, D., & Alt, E. (2010). Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. European Heart Journal, 31(4), 489–501. doi:10.1093/eurheartj/ehp568.
72. Mazo, M., Cemborain, A., Gavira, J. J., Abizanda, G., Arana, M., Casado, M., Soriano, M., Hernandez, S., Moreno, C., Ecay, M., Albiasu, E., Belzunce, M., Orbe, J., Paramo, J. A., Merino, J., Penuelas, I., Verdugo, J. M., Pelacho, B., & Prosper, F. (2012). Adipose stromal vascular fraction improves cardiac function in chronic myocardial infarction through differentiation and paracrine activity. Cell Transplantation, 21(5), 1023–1037. doi:10.3727/096368911X623862.
73. Leblanc, A. J., Touroo, J. S., Hoying, J. B., & Williams, S. K. (2012). Adipose stromal vascular fraction cell construct sustains coronary microvascular function after acute myocardial infarction. American Journal of Physiology. Heart and Circulatory Physiology, 302(4), H973–H982. doi:10.1152/ajpheart.00735.2011.
74. Premaratne, G. U., Ma, L. P., Fujita, M., Lin, X., Bollano, E., & Fu, M. (2011). Stromal vascular fraction transplantation as an alternative therapy for ischemic heart failure: anti-inflammatory role. Journal of Cardiothoracic Surgery, 6, 43. doi:10.1186/1749-8090-6-43.
75. Schenke-Layland, K., Strem, B. M., Jordan, M. C., Deemedio, M. T., Hedrick, M. H., Roos, K. P., Fraser, J. K., & Maclellan, W. R. (2009). Adipose tissue-derived cells improve cardiac function following myocardial infarction. The Journal of Surgical Research, 153(2), 217–223. doi:10.1016/j.jss.2008.03.019.
76. Alt, E., Pinkernell, K., Scharlau, M., Coleman, M., Fotuhi, P., Nabzdyk, C., Matthias, N., Gehmert, S., & Song, Y. H. (2010). Effect of freshly isolated autologous tissue resident stromal cells on cardiac function and perfusion following acute myocardial infarction. International Journal of Cardiology, 144(1), 26–35. doi:10.1016/j.ijcard.2009.03.124.
77. Yamada, Y., Wang, X. D., Yokoyama, S., Fukuda, N., & Takakura, N. (2006). Cardiac progenitor cells in brown adipose tissue repaired damaged myocardium. Biochemical and Biophysical Research Communications, 342(2), 662–670. doi:10.1016/j.bbrc.2006.01.181.
78. Leobon, B., Roncalli, J., Joffre, C., Mazo, M., Boisson, M., Barreau, C., Calise, D., Arnaud, E., Andre, M., Puceat, M., Penicaud, L., Prosper, F., Planat-Benard, V., & Casteilla, L. (2009). Adipose-derived cardiomyogenic cells: in vitro expansion and functional improvement in a mouse model of myocardial infarction. Cardiovascular Research, 83(4), 757–767. doi:10.1093/cvr/cvp167.
79. Yu, L. H., Kim, M. H., Park, T. H., Cha, K. S., Kim, Y. D., Quan, M. L., Rho, M. S., Seo, S. Y., & Jung, J. S. (2010). Improvement of cardiac function and remodeling by transplanting adipose tissue-derived stromal cells into a mouse model of acute myocardial infarction. International Journal of Cardiology, 139(2), 166–172. doi:10.1016/j.ijcard.2008.10.024.
80. Li, B., Zeng, Q., Wang, H., Shao, S., Mao, X., Zhang, F., Li, S., & Guo, Z. (2007). Adipose tissue stromal cells transplantation in rats of acute myocardial infarction. Coronary Artery Disease, 18(3), 221–227. doi:10.1097/MCA.0b013e32801235da.
81. Carvalho, J. L., Braga, V. B., Melo, M. B., Campos, A. C., Oliveira, M. S., Gomes, D. A., Ferreira, A. J., Santos, R. A., & Goes, A. M. (2013). Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction. Journal of Cellular and Molecular Medicine, 17(5), 617–625. doi:10.1111/jcmm.12036.
82. Rasmussen, J. G., Frobert, O., Holst-Hansen, C., Kastrup, J., Baandrup, U., Zachar, V., Fink, T., & Simonsen, U. (2014). Comparison of human adipose-derived stem cells and bone marrow-derived stem cells in a myocardial infarction model. Cell Transplantation, 23(2), 195–206. doi:10.3727/096368912X659871.
83. Valina, C., Pinkernell, K., Song, Y. H., Bai, X., Sadat, S., Campeau, R. J., Le Jemtel, T. H., & Alt, E. (2007). Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. European Heart Journal, 28(21), 2667–2677. doi:10.1093/eurheartj/ehm426.
84. De Siena, R., Balducci, L., Blasi, A., Montanaro, M. G., Saldarelli, M., Saponaro, V., Martino, C., Logrieco, G., Soleti, A., Fiobellot, S., Madeddu, P., Rossi, G., Ribatti, D., Crovace, A., Cristini, S., Invernici, G., Parati, E. A., & Alessandri, G. (2010). Omentum-derived stromal cells improve myocardial regeneration in pig post-infarcted heart through a potent paracrine mechanism. Experimental Cell Research, 316(11), 1804–1815. doi:10.1016/j.yexcr.2010.02.009.
85. Mazo, M., Hernandez, S., Gavira, J. J., Abizanda, G., Arana, M., Lopez-Martinez, T., Moreno, C., Merino, J., Martino-Rodriguez, A., Uixeira, A., Garcia de Jalon, J. A., Pastrana, J., Martinez-Caro, D., & Prosper, F. (2012). Treatment of reperfused ischemia with adipose-derived stem cells in a preclinical Swine model of myocardial infarction. Cell Transplantation, 21(12), 2723–2733. doi:10.3727/096368912X638847.
86. Hoke, N. N., Salloum, F. N., Kass, D. A., Das, A., & Kukreja, R. C. (2012). Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice. Stem Cells, 30(2), 326–335. doi:10.1002/stem.789.
87. Wang, W. E., Yang, D., Li, L., Wang, W., Peng, Y., Chen, C., Chen, P., Xia, X., Wang, H., Jiang, J., Liao, Q., Li, Y., Xie, G., Huang, H., Guo, Y., Ye, L., Duan, D. D., Chen, X., Houser, S. R., & Zeng, C. (2013). Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardium. Circulation Research, 113(3), 288–300. doi:10.1161/CIRCRESAHA.113.300929.
88. Fischer, U. M., Harting, M. T., Jimenez, F., Monzon-Posadas, W. O., Xue, H., Savitz, S. I., Laine, G. A., & Cox, C. S., Jr. (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells and Development, 18(5), 683–692. doi:10.1089/scd.2008.0253.
89. Preda, M. B., Ronningen, T., Burlacu, A., Simionescu, M., Moskaug, J. O., & Valen, G. (2014). Remote transplantation of mesenchymal stem cells protects the heart against ischemia-reperfusion injury. Stem Cells. doi:10.1002/stem.1687.
90. Hamdi, H., Planat-Benard, V., Bel, A., Neamatalla, H., Saccenti, L., Calderon, D., Bellamy, V., Bon, M., Perrier, M. C., Mandet, C., Bruneval, P., Casteilla, L., Hagege, A. A., Puceat, M., Agbulut, O., & Menasche, P. (2014). Long-term functional benefits of epicardial patches as cell carriers. Cell Transplantation, 23(1), 87–96. doi:10.3727/096368912X658836.
91. Paul, A., Chen, G., Khan, A., Rao, V. T., Shum-Tim, D., & Prakash, S. (2012). Genipin-cross-linked microencapsulated human adipose stem cells augment transplant retention resulting in attenuation of chronically infarcted rat heart fibrosis and cardiac dysfunction. Cell Transplantation, 21(12), 2735–2751. doi:10.3727/096368912X637497.
92. Zhang, Z., Li, S., Cui, M., Gao, X., Sun, D., Qin, X., Narsinh, K., Li, C., Jia, H., Li, C., Han, Y., Wang, H., & Cao, F. (2013). Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways. Basic Research in Cardiology, 108(2), 333. doi:10.1007/s00395-013-0333-5.
93. Berardi, G. R., Rebelatto, C. K., Tavares, H. F., Ingberman, M., Shigunov, P., Barchiki, F., Aguiar, A. M., Miyague, N. I., Francisco, J. C., Correa, A., Senegaglia, A. C., Suss, P. H., Moutinho, J. A., Sotomaior, V. S., Nakao, L. S., & Brofman, P. S. (2011). Transplantation of SNAP-treated adipose tissue-derived stem cells improves cardiac function and induces neovascularization after myocardium infarct in rats. Experimental and Molecular Pathology, 90(2), 149–156. doi:10.1016/j.yexmp.2010.11.005.
94. Chang, J. C., Lee, P. C., Lin, Y. C., Lee, K. W., & Hsu, S. H. (2011). Primary adipose-derived stem cells enriched by growth factor treatment improves cell adaptability toward cardiovascular differentiation in a rodent model of acute myocardial infarction. Journal of Stem Cells, 6(1), 21–37.
95. Kim, S. W., Lee, D. W., Yu, L. H., Zhang, H. Z., Kim, C. E., Kim, J. M., Park, T. H., Cha, K. S., Seo, S. Y., Roh, M. S., Lee, K. C., Jung, J. S., & Kim, M. H. (2012). Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model. Cardiovascular Research, 95(4), 495–506. doi:10.1093/cvr/cvs224.
96. Paul, A., Nayan, M., Khan, A. A., Shum-Tim, D., & Prakash, S. (2012). Angiopoietin-1-expressing adipose stem cells genetically modified with baculovirus nanocomplex: investigation in rat heart with acute infarction. International Journal of Nanomedicine, 7, 663–682. doi:10.2147/IJN.S26882.
97. Shi, C. Z., Zhang, X. P., Lv, Z. W., Zhang, H. L., Xu, J. Z., Yin, Z. F., Yan, Y. Q., & Wang, C. Q. (2012). Adipose tissue-derived stem cells embedded with eNOS restore cardiac function in acute myocardial infarction model. International Journal of Cardiology, 154(1), 2–8. doi:10.1016/j.ijcard.2011.05.078.
98. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411), 143–147.
99. Fraser, J. K., Wulur, I., Alfonso, Z., & Hedrick, M. H. (2006). Fat tissue: an underappreciated source of stem cells for biotechnology. Trends in Biotechnology, 24(4), 150–154. doi:10.1016/j.tibtech.2006.01.010.
100. Ivanova-Todorova, E., Bochev, I., Mourdjeva, M., Dimitrov, R., Bukarev, D., Kyurkchiev, S., Tivchev, P., Altunkova, I., & Kyurkchiev, D. S. (2009). Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells. Immunology Letters, 126(1–2), 37–42. doi:10.1016/j.imlet.2009.07.010.
101. Kim, Y., Kim, H., Cho, H., Bae, Y., Suh, K., & Jung, J. (2007). Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 20(6), 867–876. doi:10.1159/000110447.
102. Hsiao, S. T., Asgari, A., Lokmic, Z., Sinclair, R., Dusting, G. J., Lim, S. Y., & Dilley, R. J. (2012). Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. Stem Cells and Development, 21(12), 2189–2203. doi:10.1089/scd.2011.0674.
103. Houtgraaf, J. H., den Dekker, W. K., van Dalen, B. M., Springeling, T., de Jong, R., van Geuns, R. J., Geleijnse, M. L., Fernandez-Aviles, F., Zijlsta, F., Serruys, P. W., & Duckers, H. J. (2012). First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. Journal of the American College of Cardiology, 59(5), 539–540. doi:10.1016/j.jacc.2011.09.065.
104. Perin, E. C., Sanz-Ruiz, R., Sanchez, P. L., Lasso, J., Perez-Cano, R., Alonso-Farto, J. C., Perez-David, E., Fernandez-Santos, M. E., Serruys, P. W., Duckers, H. J., Kastrup, J., Chamuleau, S., Zheng, Y., Silva, G. V., Willerson, J. T., & Fernandez-Aviles, F. (2014). Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial. American Heart Journal, 168(1), 88–95 e82. doi:10.1016/j.ahj.2014.03.022.
105. Qayyum, A. A., Haack-Sorensen, M., Mathiasen, A. B., Jorgensen, E., Ekblond, A., & Kastrup, J. (2012). Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design. Regenerative Medicine, 7(3), 421–428. doi:10.2217/rme.12.17.
106. Schulman, I. H., & Hare, J. M. (2012). Key developments in stem cell therapy in cardiology. Regenerative Medicine, 7(6 Suppl), 17–24.
107. Naaijkens, B. A., van Dijk, A., Kamp, O., Krijnen, P. A., Niessen, H. W., & Juffermans, L. J. (2014). Therapeutic application of adipose derived stem cells in acute myocardial infarction: lessons from animal models. Stem Cell Reviews. doi:10.1007/s12015-014-9502-7.